Journey Medical (DERM) Notes Payables (2020 - 2023)

Journey Medical's Notes Payables history runs 4 years deep, the most recent figure standing at $370000.0 for Q1 2023.

• Quarterly Notes Payables fell 27.59% year-over-year to $370000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $370000.0 (down 27.59% YoY) and the FY2022 annual result came in at $413000.0, down 35.57% from the prior year.
• Notes Payables was $370000.0 for Q1 2023 at Journey Medical, down from $413000.0 in the prior quarter.
• Across five years, Notes Payables topped out at $641000.0 in Q4 2021 and bottomed at $74000.0 in Q3 2022.
• A 4-year average of $385375.0 and a median of $391500.0 in 2022 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2021 — Notes Payables jumped 447.86% — and 2022, when it sank 87.67%.
• Journey Medical's Notes Payables stood at $117000.0 in 2020, then soared by 447.86% to $641000.0 in 2021, then slumped by 35.57% to $413000.0 in 2022, then dropped by 10.41% to $370000.0 in 2023.
• Business Quant data shows DERM's Notes Payables at $370000.0 in Q1 2023, $413000.0 in Q4 2022, and $74000.0 in Q3 2022.